task
0 (0 Likes / 0 Dislikes)
Hello people
Hummmm...
I want to talk to you about
a Covid-19 vaccine,
OK?
The one developed
by the University of Oxford,
together with a transgenic company,
alright?
Recently,
they published
the results
for the oral efficacy of the vaccine,
and this...
The number was 70%.
Now, compared to the other two,
with numbers around 90/95%,
this would be bad.
However,
It turns down
that they made a mistake
with about 3000 people volunteers,
and, because
they gave to these people
allow a dose
regimen of the vaccine.
So basically,
they gave the same amount of liquid,
but that was less
an amount of vaccine in the liquid,
it was diluted.
So...
this was a mistake,
very intense out,
that when you do that
in the first dose,
and then you give
the full amount on the second,
it looks like...
the oral efficacy
rises from 70 to 90%.
Now, taking into a count
that this vaccine
is cheaper than the other two,
it's in the round of 2 or 3€ well,
and 20, whatever, and
that it can be stored in fridges,
alright?
At fridge temperature,
around 8 degrees positive,
around 20 or 30 minutes.
Early, so, of course,
that all dose characteristics
made this vaccine much better...
So, the only problem would be
the lower efficacy,
but, if it turns out that
the oral efficacy,
it's actually in the round of 90%,
then, that's really good.
So, it looks like
they are going to make new trials now.
But then, of course,
some people are saying:
"Ah, they're making new ones,
because they didn't do it right
in the first time.", and someone.
So it's tricky.